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Abstract
Schistosomes are parasitic platyhelminths that currently infect over 200 million people globally. The parasites can live for
years in a putatively hostile environment - the blood of vertebrates. We have hypothesized that the unusual schistosome
tegument (outer-covering) plays a role in protecting parasites in the blood; by impeding host immunological signaling
pathways we suggest that tegumental molecules help create an immunologically privileged environment for schistosomes.
In this work, we clone and characterize a schistosome alkaline phosphatase (SmAP), a predicted ,60 kDa glycoprotein that
has high sequence conservation with members of the alkaline phosphatase protein family. The SmAP gene is most highly
expressed in intravascular parasite life stages. Using immunofluorescence and immuno-electron microscopy, we confirm
that SmAP is expressed at the host/parasite interface and in internal tissues. The ability of living parasites to cleave
exogenous adenosine monophosphate (AMP) and generate adenosine is very largely abolished when SmAP gene
expression is suppressed following RNAi treatment targeting the gene. These results lend support to the hypothesis that
schistosome surface enzymes such as SmAP could dampen host immune responses against the parasites by generating
immunosuppressants such as adenosine to promote their survival. This notion does not rule out other potential functions
for the adenosine generated e.g. in parasite nutrition.
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Introduction
Schistosomes are parasitic platyhelminths that constitute an
important public health problem globally. Infection can lead to a
chronic, often debilitating disease that afflicts more than 200
million people in over 70 countries worldwide [1,2]. Mortality is
estimated at over a quarter of a million deaths annually in sub-
Saharan Africa alone, with many millions more experiencing
chronic morbidity [1,2]. Schistosome infection is characterized by
the presence of relatively large adult worms (blood flukes) within
the vasculature of their hosts. Schistosomes in the bloodstream
are surrounded by all the components of immunity, yet remain
able to survive, sometimes for decades. This means that they must
possess evasion strategies that can overcome anti-worm immune
mechanisms. While parasite eggs laid by female worms are
vigorously targeted by the host immune response, there is no
overt cellular inflammation detected around the adult worms
themselves in the vasculature [3]. This is the case despite the fact
that the adult parasites are relatively big and possess a large
interface with the host. One major interface between the
schistosome and its external environment is the tegument. This
is a unique, syncytial structure that is bounded externally by a
dual lipid bilayer [4,5,6,7]. This double-bilayered (or heptalami-
nate) membrane is unique to blood-dwelling trematodes such as
schistosomes and is not found in trematode parasites occupying
other habitats [8]. We are interested in understanding how this
structure contributes to schistosome success. It is clear that the
tegument surface contains molecules that perform vital functions
such as nutrient uptake [9,10]. Less clear is how, or if, the
structure contributes to the ability of the worms to avoid immune
elimination. In this report we focus on the schistosome surface
alkaline phosphatase (SmAP) a protein which we hypothesize
plays a role in immune evasion by generating the potent
immunosuppressant adenosine. Since adenosine is also an
important nutrient, SmAP may also play a role in parasite
feeding.
Methods
Ethics Statement
Infection of mice with schistosome parasites was carried out
following review and approval by the Institutional Animal Care
and Use Committee of Tufts University. The Tufts animal
management program is accredited by the American Association
for the Accreditation of Laboratory Animal Care, meets the
National Institutes of Health standards as set forth in the ‘‘Guide
for the Care and Use of Laboratory Animals’’ (National Academy
Press, Washington DC, 1996), and accepts as mandatory the PHS
‘‘Policy on Humane Care and Use of Laboratory Animals by
Awardee Institutions’’ and NIH ‘‘Principals for the Utilization and
Care of Laboratory Animals Used in Testing, Research and
Training’’.
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Biomphalaria glabrata snails infected with the Puerto Rican strain of
S. mansoni were obtained from Dr. Fred Lewis (Biomedical Research
Institute, Rockville, MD). Schistosomula were prepared from
cercariae released from infected snails and were cultured in Basch
medium (lacking red blood cells (rbcs)) at 37uC, in an atmosphere
of 5% CO2 as described [11]. Adult worms were recovered by
vascular perfusion from Balb/c mice that were infected with 125
cercariae, 7 weeks previously. Adult worms were maintained in
Basch medium (lacking rbcs). Parasite eggs were isolated from
infected mouse liver tissue, miracidia were recovered, and
sporocysts were prepared and cultured for 24 h, as described
previously [12].
Cloning SmAP
An expressed sequence tag (EST) encoding a fragment of a
putative S. mansoni alkaline phosphatase (EST269800) was
identified in the adult female cDNA library of Phil LoVerde/Joe
Merrick (GenBank accession number AI975206). Using this
information, we designed two specific SmAP oligonucleotides for
use with the Smart RACE cDNA amplification kit (Clontech, CA)
to amplify the entire coding region. The oligonucleotides were
synthesized based on sequence of the predicted 39untranslated
region of the EST. The 39-most specific oligonucleotide (AP-3: 59-
GTAATATTTATTAGGTTAGATTAG-39) was used to synthe-
size cDNA. The second oligonucleotide (AP-4: 59-CATGTTAAT-
CATGTAAGTATATTT-39) was used, together with the Smart
RACE kit anchor primer and the cDNA, in a semi-nested PCR
following the manufacturer’s instructions, in order to amplify the
complete SmAP coding DNA presented here. The ,1.5 kb PCR
product was excised from an agarose gel using a GeneClean kit
(Bio101, CA) and sequenced.
Anti-SmAP antibody production
A peptide comprising SmAP amino acid residues 44–65
(NH2-SADERFNKFEKSLSYLLLKRPK-COOH) was synthe-
sized by Genemed Synthesis, Inc., TX. This sequence is
indicated in bold script in Fig. 1. A cysteine residue was added
at the amino-terminus to facilitate conjugation of the peptide to
bovine serum albumin (BSA). Approximately 500 mgo ft h e
peptide-BSA conjugate in Freund’s Complete Adjuvant was
used to immunize a New Zealand white rabbit subcutaneously.
The rabbit was boosted with 100 mgp e p t i d ea l o n ei n
Incomplete Freund’s Adjuvant 20, 40 and 60 days later. Ten
days following this, serum was recovered and anti-SmAP
antibodies were affinity purified using a peptide-ovalbumin
conjugate and dialysed against phosphate buffered saline (PBS),
as previously described [13].
SmAP gene expression analysis
The levels of expression of the SmAP gene in different life cycle
stages was measured by quantitative real time PCR (qRT-PCR)
using the housekeeping gene triose phosphate isomerase as the
endogenous control [14]. In unpublished work we have identified
a greater uniformity in expression of the triose phosphate
isomerase gene (TPI) between different schistosome life stages
and we use this as the endogenous control in the developmental
expression work presented here. The procedure, involving total
RNA extraction and qRT-PCR, has been described [14]. Briefly,
RNA was first extracted using the Trizol method (Invitrogen, CA)
and residual DNA was removed by DNase digestion using a
TurboDNA-free kit (Applied Biosystems, TX). cDNA was
synthesized using 1 mg RNA, an oligo (dT)20 primer and
Superscript III RT (Invitrogen, CA).
Quantitative real time PCR was performed using custom
TaqMan Assays using primer sets and reporter probes labeled with
6-carboxyfluorescein (FAM), obtained from Applied Biosystems,
CA. To detect SmAP expression the following primers and probe
were used: SmAP1Taq-siteF, 59-GCCATCCGACAAGGAATA-
TAAGTGT-39; SmAP1Taq-siteR, 59-GGTCCATTGAAAAAG-
GAGGATATGAGA-39and probe, SmAP1Taq-siteM2, 59-FAM-
ATCTCCTTTTGCAGTATTATC-39. Each real-time TaqMan
PCR was performed using cDNA equivalent to 10 ng total
parasite RNA according to the manufacturer’s universal condi-
tions PCR protocol, in a final volume of 25 ml. All samples were
run in triplicate and underwent 40 amplification cycles on a 7500
ABI PRISM Sequence Detection System Instrument. For relative
quantification, the DDCt method was employed [15]. Data shown
are representative of at least 3 replicate experiments.
Membrane preparation, gel electrophoresis and western
blotting analysis
Membrane extracts from different parasite life stages were
prepared [16] and aliquots from each were resolved by 4–15%
gradient SDS-PAGE. One gel was stained with Coomassie Blue
and protein from a duplicate gel was blotted to PVDF membrane,
as previously outlined [13]. Blots were probed with purified anti-
SmAP antibodies at 1:300 dilution and bound antibody was
detected using a horseradish peroxidase-labeled anti-rabbit IgG
(1:5000, GE Healthcare, NJ) and the TMB Membrane Peroxidase
system from Kirkegaard and Perry Laboratories Inc, MD,
following the manufacturer’s instructions. Blot images were
captured using a Kodak Image Station 2000RT.
In one experiment, the reducing agent dithiothreitol (DTT) was
omitted from the gel electrophoresis sample buffer prior to protein
resolution by SDS-PAGE. One lane from such a gel was incubated
overnight in alkaline phosphatase substrate (1 mg/ml 5-Bromo-4-
Chloro-3-Indolyl-Phosphate (BCIP) in 50 mM Tris HCl, pH 7.6)
to visualize protein bands displaying enzymatic activity[17]. A
second lane was blotted to PVDF membrane and processed for
western blotting analysis, as outlined in the preceding paragraph.
Author Summary
Schistosomes are parasitic worms that live for many years
in the blood stream of ,200 million people globally. How
they manage to avoid getting killed by host immune
mechanisms is a puzzle. We hypothesize that molecules in
their skin (tegument), e.g. the enzyme alkaline phospha-
tase (SmAP), help them in this regard. In this work, we
characterize SmAP. It is predicted to be a ,60 kDa
glycoprotein that is most highly expressed in those
parasite life stages that live inside a mammalian host. We
confirm that SmAP is expressed at the host/parasite
interface as well as in internal tissues. To monitor the
function of the enzyme, we have suppressed the
expression of the SmAP gene using RNA interference.
These parasites largely loose their ability to cleave the
added substrate AMP (adenosine monophosphate) to
generate adenosine. Since adenosine is very efficient at
dampening host immune mechanisms, our work lends
support to the idea that one function for tegumental
SmAP is to generate the immunosuppressant adenosine so
that the worms can remain unperturbed by host immune
effectors. Our results do not preclude other functions for
the generated adenosine. For example it could also be
taken up as a nutrient by the parasites.
Schistosome Tegumental Alkaline Phosphatase
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Adult worm sections 7 mm thick were obtained using a cryostat
and fixed in cold acetone. Immunofluorescent detection of SmAP
was carried out using affinity-purified, rabbit anti-SmAP antise-
rum diluted 1:20 and Alexa fluor 488-conjugated goat anti-rabbit
IgG (Invitrogen, CA), essentially as described earlier [18].
Immunogold Labeling and Electron Microscopy
Freshly perfused adult parasites were fixed overnight with 2%
glutaraldehyde in 0.1 M cacodylate buffer at 4uC. The samples
were then dehydrated in a graded series of ethanol, then infiltrated
and embedded in L.R. white acrylic resin. Ultramicrotomy was
performed using a Leica Ultracut R ultramicrotome and the
sections collected on gold grids. Grids were immunolabeled in a
two step method according to the following procedure; the grids
were conditioned in PBS for 5 min63 at room temperature (RT),
followed by the blocking of non-specific labeling for 30 min at RT
using 5% non-fat dry milk in PBS. After rinsing, the grids were
exposed to primary antibody diluted 1:30 for 1 hour at RT,
followed by washing in PBS and then incubated with secondary
antibody diluted 1:30 (10 nm gold-labeled goat anti-rabbit IgG
(H&L, GE Healthcare, NJ)) for 1 hour at RT, and finally rinsed
thoroughly in water. The grids were exposed to osmium vapor
and/or lightly stained with lead citrate to improve contrast and
were examined and photographed using a Philips CM 10 electron
microscope at 80 KV.
Treatment of parasites with siRNAs
Adult worms were treated either with a synthetic siRNA
targeting SmAP and designated SmAPsiRNA 1 (59-AAGAAAT-
CAGCAGATGAGAGATTTAAT-39) or with control siRNAs.
Control siRNAs were of two forms, the first targeted an unrelated
schistosome gene (encoding a phosphodiesterase, GenBank
accession number EU769293; Sm control; 59-TTGATG-
GATTTCGTTATGATTACTTTG-39) and the second targeted
no sequence in the schistosome genome. The sequence of this
‘‘irrelevant control’’ is 59-CTTCCTCTCTTTCTCTCCCTT-
GTGA-39. Delivery of siRNAs to the parasites was performed
by electroporation as described previously, using 10 mg of each
siRNA [14,19]. Gene suppression was assessed post-treatment by
comparing mRNA and protein levels in target versus control
groups.
To assess the level of suppression post-siRNA treatment, RNA
and protein were isolated from worm lysates (PARIS kit, Applied
Biosystems, CA). To monitor SmAP levels at the RNA level, the
same qRT-PCR protocol described above was employed but here
using the alpha tubulin gene as the endogenous control for each
sample, as previously [15]. For graphical representation, the DDCt
values were normalized to controls and expressed as percent
difference [15]. Results were graphed as gene expression level
relative to the group treated with control irrelevant siRNA. To
monitor SmAP levels at the protein level, western blotting analysis
was carried out essentially as described previously [20]. To
monitor protein loading per lane, a duplicate gel was stained with
Coomassie Brilliant Blue.
Alkaline phosphatase activity of live adult worms
Eight days after RNAi treatment,thealkaline phosphataseactivity
of live adult worms was assessed by culturing 6 SmAP-suppressed
and control parasites in triethanolamine buffer, pH 8.9, containing
chromogenic substrate p-nitrophenyl phosphate (p-NPP, Sigma-
Aldrich, MO) at 37uC in a final volume of 1 ml. After 30 min
incubation, 400 ml of culture supernatant was recovered and read at
OD 405 nm. Buffer containing substrate alone served as a blank.
AMP degradation and adenosine generation by live adult
worms
EightdaysafterRNAitreatment,12adultmaleSmAP-suppressed
and control parasites were incubated at 37uCi nR P M Im e d i u m
lacking fetal calf serum and containing 500 mM AMP (Sigma-
Aldrich, MO). Samples (70 ml) of culture media were withdrawn at
selected time points and the levels of AMP and adenosine they
contained was measured using high performance liquid chromatog-
raphy (HPLC). HPLC assays was performed by loading samples
onto a strong anion-exchange partisphere SAX column (Whatman/
GE Healthcare, NJ) with a linear gradient from 7 mM KH2PO4,
pH 3.8 to 0.5 M KH2PO4, pH 4.5 for 60 min and a flow rate of
0.5 ml/min [21]. For standardization, purified AMP and adenosine
(Sigma-Aldrich, MO) in RPMI were first applied to the column and
their characteristic elution profiles determined.
Statistical analysis
The student’s t-test was used to compare the means between a
target group and a control group and p values less than 0.05 were
considered significant.
Results
Sequence analysis
The cloned SmAP DNA potentially encodes a 536 amino acid
protein of 59,375 Da and a pI of 5.92. The GenBank accession
number for SmAP is EU040139. An alignment of this protein with
other members of the alkaline phosphatase family using CLUS-
TALW is shown in Fig. 1 and several conserved motifs are
highlighted. The designations of the compared proteins are as
follows: Hs, Homo sapiens, tissue non-specific alkaline phosphatase;
Dm, Drosophila melanogaster; Sc, the yeast Saccharomyces cerevisiae.
SmAP exhibits a higher percent sequence identity with other
animal alkaline phosphatases (33–34% versus human and D.
melanogaster homologs) compared to the yeast enzyme (22%). In
SmAP, active site residues S
123 and R
198 are highly conserved
(indicated by #, Fig. 1) as are residues reported to be important in
metal binding (D
73,H
185,T
187,E
338,D
343,H
344,H
347,D
384,
H
385,H
459, indicated by *). The 28 amino acid, N-terminal,
sequence (
1MLPTVLSTASKPLLFFIAVILSLYKIEC
28) is a po-
tential signal peptide (using SignalP 3.0, http://www.cbs.dtu.dk/
services/SignalP-3.0/), and this sequence is underlined. The
protein has a single predicted transmembrane domain at the
carboxyl terminus,
514SGLHLNNFYYLLFLSIILYTFI
535, under-
lined in Fig. 1. The best potential site for GPI-linked modification
is S
492 (bold, Fig. 1), as determined at http://mendel.imp.ac.at/
Figure 1. Alignment of SmAP predicted amino acid sequence with homologs. Designations and GenBank accession numbers of these
proteins are: SmAP, Schistosoma mansoni (EU040139); Hs, Homo sapiens (NP000469); Dm, Drosophila melanogaster (NP649315) and Sc, Saccharomyces
cerevisiae (AAA34871). Identical residues are indicated by shading. Proposed active site residues are indicated by # and residues reported to be
important in metal binding are indicated by *. A potential signal peptide sequence at the N-terminal end and a single predicted transmembrane
domain at the C-terminus are both underlined. A potential site for GPI-linked modification is S
492, indicated in bold. Conserved cysteine residues are
boxed. The peptide sequence from residue 44 to 65, used to generate anti-SmAP antibodies, is indicated in bold. Underlined asparagine (N) residues
indicate several potential N-linked glycosylation sites.
doi:10.1371/journal.pntd.0001011.g001
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peptide
44SADERFNKFEKSLSYLLLKRPK
65, used to generate
anti-SmAP antibodies is in bold. Underlined asparagine (N)
residues indicate several potential N-linked glycosylation sites.
Developmental expression
The developmental expression of SmAP was examined in
several life stages by qRT-PCR and results are shown in Fig. 2A.
Gene expression is clearly detected in all life stages examined and
relative expression is highest in the intra-mammalian life stages
(schistosomula and adults).
In schistosome protein extracts, anti-SmAP antibodies detect a
prominent band (arrowhead, Fig. 2B), running at the predicted
size of SmAP (,60 kDa) by western analysis in all life stages
examined, namely: eggs, cercariae, schistosomula and adult male
and female worms, when extracts are resolved in the presence of
reducing agent. The adult membrane preparation was also
resolved either in the presence (Fig. 2C, lane 1) or absence
(Fig. 2C, lane 2) of the reducing agent DTT. In the absence of this
reagent, an additional ,120 kDa species is detected in the extract
which may represent the SmAP homodimer (arrow, Fig. 2C, lane
2). This dimeric form is predicted to be the functional enzyme.
Indeed, in gel slices incubated with alkaline phosphatase substrate
(BCIP), reaction product is detected at the same position
(,120 kDa, arrow, Fig. 2C, lane 3).
Localization of SmAP in adult tissues
SmAP is widely distributed throughout adult male and female
worms as determined by immunolocalization (Fig. 3A). Parasite
muscle and parenchymal tissue stain clearly with anti-SmAP
antibodies. Fig. 3B shows a higher magnification image of the
periphery of an adult male section where the outer region of the
tegument shows clear staining (arrow). Localization of SmAP by
immunogold electron microscopy (Fig. 3C) confirms that the protein
is distributed on the host-interactive tegumental membranes. Arrows
in Fig. 3C point to some of the tegumental immunogold particles at
the hostparasite interface. Parasites treated with secondary antiserum
alone demonstrate no tissue staining (data not shown).
SmAP gene suppression
SmAP gene expression was suppressed in adult parasites in vitro
by introducing a target specific siRNA using electroporation.
Fig. 4A shows the specific and robust suppression of SmAP
(,95%), measured by qRT-PCR, 8 days after treatment. Western
blot analysis demonstrates that this treatment also results in
substantial diminution in SmAP protein production (arrow,
Fig. 4B). The lower panel in Fig. 4B shows a fragment of a
Coomassie Blue stained polyacrylamide gel, distant from the
location of SmAP, to illustrate that all lanes contain roughly
equivalent amounts of parasite protein.
This robust suppression of SmAP does not result in any
detectable change in adult parasite morphology or behavior.
However, living adult parasites whose SmAP expression is
suppressed by RNAi treatment, unlike controls, have a greatly
diminished ability to cleave the chromogenic substrate, p-
nitrophenyl phosphate (p,0.01, Fig. 5A). In addition, relative to
controls, the SmAP-suppressed parasites are significantly impaired
in their ability to cleave the nucleotide, AMP (p,0.01, Fig. 5B)
and to generate the reaction product adenosine (p,0.01, Fig. 5C).
Figure 2. SmAP detection and expression. A. Expression of the
SmAP gene in different schistosome developmental stages. Egg,
sporocyst (Sp), cercaria (Cer), 24 h-cultured schistosomulum (som),
adult female (F) and adult male (M), B. SmAP protein expression in
membrane preparations from different schistosome developmental
stages. Adult male (M), adult female (F), 24 h-cultured schistosomulum
(Som), cercaria (Cer) and egg. The arrowhead indicates the position of
the SmAP protein. Molecular mass markers are depicted in the right
lane and sizes are indicated in kDa. C. Adult male and female worm
extract was resolved in the presence (lane 1) or absence (lanes 2 and 3)
of reducing agent by SDS-PAGE. Lanes 1 and 2 represent western blots
of the extract probed with anti-SmAP antibodies. The arrowhead
indicates the position of the SmAP monomeric protein (at ,60 kDa)
while the arrow indicates the proposed homodimeric form (running at
,120 kDa). Lane 3 represents one tract of the gel after incubation with
the alkaline phosphatase substrate BCIP. The arrow indicates a band of
activity at ,120 kDa.
doi:10.1371/journal.pntd.0001011.g002
Figure 3. Immunolocalization of SmAP in adult parasites. A.
Cross section through a male/female couple showing widespread
immunofluorescent staining witha n t i - S m A Pa n t i b o d y .B .H i g h e r
magnification image of the peripheral tissue of an adult male. The
arrow indicates the outer tegument. C. Electron micrograph of the adult
tegument showing immunogold labeling of SmAP. Arrows indicate
gold particles at the host-parasite interface. Numbers above scale bars
represent microns.
doi:10.1371/journal.pntd.0001011.g003
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In this report we describe the cloning and characterization of a
Schistosoma mansoni alkaline phosphatase (SmAP). Alkaline phos-
phatases (EC 3.1.3.1) are dimeric enzymes present in most, if not
all, organisms. They catalyze the hydrolysis of phosphomonoesters
with the release of inorganic phosphate. The SmAP cloned here is
predicted to be a ,60 kDa protein that possesses six potential N-
linked glycosylation sites. This is in broad agreement with earlier
work in which the enzyme was purified from Triton X-100
extracts of adult parasites following ConA agarose affinity
chromatography and shown to be composed of ,65 kDa
glycosylated subunits [22]. Here we show that in adult schistosome
extracts, anti-SmAP antibodies detect a protein of about this size
by western blotting. Under non-reducing conditions an additional
,120 kDa species is detected which likely represents the SmAP
homodimer. Cysteine residues conserved in SmAP (boxed in Fig. 1)
are probably important in protein dimerization. It appears that the
120 kDa molecule is functionally active since reaction product is
detected at this site in gel slices incubated with alkaline
phosphatase substrate. This is in agreement with the observation
that enzyme active site residues and those coordinating metal ion
binding are highly conserved in the predicted SmAP protein. No
activity of the ,60 kDa monomeric SmAP form is apparent. It has
been reported in other systems that significant conformational
changes occur during alkaline phosphatase dimerization that
enhance thermal stability, metal binding and catalysis [23]. Thus
alkaline phosphatases from several organisms, existing in a dimeric
quaternary structure, are functional while their monomeric forms
are inactive [23].
SmAP is highly expressed in the adult tegument as shown by
immunofluorescence and immuno-electron microscopy and this
concurs with previous work in which alkaline phosphatase activity
was detected in worm sections on the external surface of the
tegument [4,24,25]. Localization using immuno-EM shows that a
majority of the immunogold particles appear to be distributed at
the edge of surface pits which is consistent with a host interactive
localization of this enzyme in the tegument. High alkaline
phosphatase activity was previously reported in tegument enriched
fractions of both male and female worms [26,27,28]. More recent
tegumental proteomic analysis confirms that the protein is found
in the schistosome surface membranes [29,30] and is available for
surface biotinylation [31]. Alkaline phosphatase activity was also
previously detected in the material released from cultured
schistosomula following phosphatidylinositol phospholipase C
treatment, suggesting that some of the enzyme is phosphatidyl
inositol anchored at the surface [32]. This is in keeping with SmAP
sequence analysis which reveals the presence of a potential site for
GPI-linked modification at residue S
492. Immunological detection
of SmAP reveals that the protein is also widely expressed in the
internal tissues of the adult parasites and this corroborates earlier
reports also detecting high levels of alkaline phosphatase enzyme
activity internally [24,33].
We have hypothesized that the function of schistosome
tegumental SmAP is to bias host purinergic signaling pathways
towards the generation of anti-inflammatory molecules such as
adenosine [34]. In this work we show that living schistosomes can
generate adenosine from exogenous AMP. This ability is effectively
abolished when the expression of SmAP is suppressed following
RNAi treatment. This result suggests that SmAP, a GPI-linked
enzyme at the tegument surface, can access exogenous AMP and
cleave it to generate adenosine. Extracellular adenosine is a potent
immunosuppressant; it has been shown to be capable of dampening
many facets of hostimmunity [35,36,37]. For instance, it caninhibit
pro-inflammatory cytokine production and chemotactic responses
of macrophages and monocytes as well as impairing macrophage
proliferation, phagocytosis and lysosymal enzyme secretion [38,39].
In addition, adenosine can inhibit reactive nitrogen species and
reactive oxygen species production by monocytes/macrophages
[40] and can impede lymphocyte adhesion and attenuate the
proliferative and cytotoxic responses of activated T cells [41,42].
Extracellular adenosine has been shown to inhibit adhesion of
neutrophils to vascular endothelial cells and, at higher concentra-
tions, to induce apoptosis of promyelocytes [43,44,45]. Adenosine
can inhibit the generation of reactive oxygen species and the
oxidative burst by immunostimulated neutrophils, as well as inhibit
neutrophil degranulation and the generation of several inflamma-
tory mediators [46]. Our data show that tegumental SmAP can
generate adenosine and it seems likely that such an ability would
benefit schistosomes by lessening the potential for inflammation and
creating a less immunologically hostile, local environment for the
parasites.Otherpathogens,andsome tumors, havealsobeen shown
to generate adenosine as a proposed immunosuppressant [36,47].
Since SmAP can be efficiently suppressed without adverse impact
on parasite viability in culture this suggests that the protein does not
fulfill an essential function for parasites in vitro and is consistent with
a role for this molecule in vivo.
Figure 4. Suppression of SmAP gene expression by RNAi. A:
Relative SmAP gene expression (mean6S.E.) in adult worms 10 days
after treatment with SmAP siRNA or a control siRNA targeting another
schistosome gene (Sm control) or an irrelevant control (irr control)
siRNA. B: Detection by western blot of SmAP protein in adult parasite
extracts 10 days after treatment with SmAP siRNA, a control siRNA
targeting another schistosome gene (Sm control) or an irrelevant
control (irr control) siRNA (top panel). The arrow indicates the greatly
diminished level of SmAP protein seen in extracts of parasites targeted
with SmAP siRNA (left lane). The bottom panel shows a strip of the gel
stained with Coomassie blue to illustrate roughly equivalent protein
loadings in each lane.
doi:10.1371/journal.pntd.0001011.g004
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identified at the schistosome surface, including a phosphodiester-
ase and an ATPdiphosphohydrolase [48,49]. Since SmAP
suppression by itself is sufficient to effectively abolish the ability
of schistosomes to cleave exogenous AMP, it is clear that these
additional enzymes are not very important in the generation of
adenosine through AMP cleavage. Since RNAi treatment results
in SmAP gene knockdown but not knockout, it is likely that the
minimal degradation of AMP seen in the SmAP suppressed group
derives from residual SmAP protein and not from the action of
other tegumental enzymes.
Since schistosomes cannot synthesize purines de novo, they must
salvage these important biomolecules from the host [50]. It is
possible that tegumental phosphatases, including SmAP, by
dephosphorylating host molecules such as AMP to generate
adenosine, play an important role in purine uptake in addition to
their proposed role in immunomodulation highlighted here [51].
The higher relative expression of SmAP in adult female parasites
lends weight to this notion.
Data reported here show that SmAP is expressed not only in the
tegument but in internal tissues and in life stages outside the
mammalian host, such as in sporocysts. Whether any adenosine
generated in the intermediate snail host can act as an
immunosuppressant is not clear since an effect of adenosine on
invertebrate immune function has not been reported. In other
systems alkaline phosphatases have been shown to play roles in a
variety of metabolic processes including lipid absorption, connec-
tive tissue mineralization, and phosphate transport [52]. In
addition to its proposed role in generating the immunosuppressant
adenosine, it is possible that SmAP also fulfills some of these
functions for schistosomes both in internal tissues and at the host-
parasite interface.
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